NYSE:CDAYCeridian HCM Stock Price, Forecast & News

Ceridian HCM's stock was trading at $56.63 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CDAY stock has increased by 46.8% and is now trading at $83.15. View which stocks have been most impacted by Coronavirus.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 2 sell ratings, 6 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Ceridian HCM.

Ceridian HCM is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Ceridian HCM.

Ceridian HCM Holding Inc (NYSE:CDAY) posted its earnings results on Wednesday, May, 6th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.03. The business earned $222.70 million during the quarter, compared to the consensus estimate of $218.42 million. Ceridian HCM had a net margin of 9.03% and a return on equity of 1.80%. Ceridian HCM's revenue was up 9.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.14 earnings per share. View Ceridian HCM's earnings history.

15 Wall Street analysts have issued 1-year target prices for Ceridian HCM's shares. Their forecasts range from $45.00 to $85.00. On average, they anticipate Ceridian HCM's share price to reach $66.82 in the next twelve months. This suggests that the stock has a possible downside of 19.6%. View analysts' price targets for Ceridian HCM.

News stories about CDAY stock have been trending neutral this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Ceridian HCM earned a coverage optimism score of 0.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Ceridian HCM.

Ceridian HCM saw a decline in short interest in the month of June. As of June 30th, there was short interest totaling 7,780,000 shares, a decline of 21.3% from the June 15th total of 9,890,000 shares. Based on an average trading volume of 1,420,000 shares, the short-interest ratio is currently 5.5 days. Currently, 6.9% of the shares of the stock are short sold. View Ceridian HCM's Current Options Chain.

Some companies that are related to Ceridian HCM include Dassault Systemes (DASTY), Electronic Arts (EA), Docusign (DOCU), Veeva Systems (VEEV), Twilio (TWLO), Splunk (SPLK), Synopsys (SNPS), Datadog (DDOG), Cadence Design Systems (CDNS), Okta (OKTA), ANSYS (ANSS), Crowdstrike (CRWD), Atlassian (TEAM), Coupa Software (COUP) and Citrix Systems (CTXS). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Paycom Software (PAYC), Advanced Micro Devices (AMD), Costco Wholesale (COST), Alteryx (AYX), Shopify (SHOP) and Tesla (TSLA).

(CDAY) raised $420 million in an IPO on Thursday, April 26th 2018. The company issued 21,000,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities served as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Ceridian HCM's stock is owned by a number of retail and institutional investors. Top institutional investors include Envestnet Asset Management Inc. (0.01%) and Nelson Van Denburg & Campbell Wealth Management Group LLC (0.00%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Paul D Elliott, Scott A Kitching and Thomas H Lee Advisors, Llc. View institutional ownership trends for Ceridian HCM.

CDAY stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc.. Company insiders that have sold Ceridian HCM company stock in the last year include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Scott A Kitching, and Thomas H Lee Advisors, Llc. View insider buying and selling activity for Ceridian HCM.

CDAY stock was acquired by a variety of institutional investors in the last quarter, including Nelson Van Denburg & Campbell Wealth Management Group LLC. View insider buying and selling activity for Ceridian HCM.

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CDAY stock can currently be purchased for approximately $83.15.

Ceridian HCM has a market capitalization of $12.06 billion and generates $824.10 million in revenue each year. The company earns $78.70 million in net income (profit) each year or $0.26 on an earnings per share basis. Ceridian HCM employs 5,011 workers across the globe.

The official website for Ceridian HCM is www.ceridian.com.

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at 952-853-8100 or via email at [email protected]